The laboratory of Dr Julien C. Marie is seeking an experienced, creative and autonomous post-doctoral fellow to study the effects of TGF-b on T cell-biology. A particular focus is proposed on deciphering mechanisms of action of TGF-b in controlling gut inflammation associated cancer using both in vitro in vivo models. Lab publications related to the topic: Marie et al Immunity 2006, Doisne et al J. Exp. Med 2009, Ruiz et al Nature Com 2014, Worthington et al Immunity 2015. Mc Carron et al Nature Com. The selected candidate will join a dynamic research team composed of 12 people for a 2 year period potentially extended.
Supported by the European Commission, the conference will bring together world’s leading researchers, ELSI experts, health economists, payers, patients and industry representatives, regulatory authorities and HTA experts and ICPerMed members including ministries representatives, research funding and policy organisations.
Within the last years, ICPerMed gathered and analysed needs from relevant stakeholders, defining challenges and actionable levers. In this context, ICPerMed developed a Vision Paper focusing on five challenges or perspectives in personalised medicine :
- Citizen engagement,
• Involvement of health providers,
• Implementation within healthcare systems,
• Health-related information,
• Economic value of implementation.
In the Vision Paper, ICPerMed provides keys on how to cross personalised medicine barriers through essential and transversal pillars that will allow improved therapy, diagnostic and preventive approaches, as well as new healthcare concepts for the benefit of citizens and patients.
During the conference, ICPerMed will be committed to demonstrate the importance and the need to address personalised medicine challenges through the prism of these critical pillars focusing on data & technology, intersectoral synergies and education & literacy necessary to initiate the translation into healthcare systems. To this end, the conference will comprise keynote lectures focusing on the implementation of personalised medicine approaches into healthcare systems for the benefit of patients, citizens and the society as a whole. In addition, in a specific dedicated session, ICPerMed will feature and honour best practices in personalised medicine research through the ICPerMed Recognition 2020, that aims to recognise, encourage, promote and disseminate outstanding examples.
Further information about the conference, the venue and the Scientific Committee Panel are available here :
Please register via the further link :
For further information about the conference, please contact [email protected]
ICPerMed provides a platform to initiate and support communication and exchange on personalised medicine research, funding and implementation. ICPerMed assembles over 40 European and international partners representing ministries, funding agencies and the European Commission. With the support of the ICPerMed Secretariat, the consortium works on coordinating and supporting research to develop approaches for personalised medicine. Thereby, the central aim of ICPerMed is to align and encourage joint efforts in personalised medicine research and implementation on a European and international level. The ICPerMed Secretariat is coordinated by partners from France, Germany, Italy and Spain.